4 Quotes by Gary Buehler

We believe that giving consumers a choice of safe, effective and reasonably-priced alternatives is extremely important to the economy and well-being of the American public.

We get 40 to 50 first-generic submissions a year, and we make quick decisions and approvals on them, often on the same day the patent or exclusivity expires.

We are very aware that many, many people are waiting for more generics to be approved and that there is frustration about the backlog.

The generic-drug program is very important to the F.D.A..